BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.2900
-0.0224 (-7.17%)
At close: Jul 24, 2026, 4:00 PM EDT
0.2857
-0.0043 (-1.48%)
Pre-market: Jul 27, 2026, 4:00 AM EDT
BioRestorative Therapies Market Cap
BioRestorative Therapies has a market cap or net worth of $7.39 million as of July 24, 2026. Its market cap has decreased by -42.28% in one year.
Market Cap
7.39M
Enterprise Value
3.83M
1-Year Change
-42.28%
Ranking
Category
Stock Price
$0.29
ChartMarket Cap Chart
Since November 5, 2021, BioRestorative Therapies's market cap has increased from $6.50M to $7.39M, an increase of 13.67%. That is a compound annual growth rate of 2.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 7.40M | -28.85% |
| Dec 31, 2025 | 10.40M | 5.05% |
| Dec 31, 2024 | 9.90M | 20.73% |
| Dec 29, 2023 | 8.20M | -18.81% |
| Dec 30, 2022 | 10.10M | -33.55% |
| Dec 31, 2021 | 15.20M | 133.85% |
| Nov 5, 2021 | 6.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aprea Therapeutics | 7.83M |
| CNS Pharmaceuticals | 7.64M |
| MetaVia | 7.64M |
| Traws Pharma | 7.40M |
| Bolt Biotherapeutics | 7.36M |
| Can-Fite BioPharma | 7.34M |
| Processa Pharmaceuticals | 7.15M |
| Niki BioSolutions | 6.82M |